JOSE CARO, M.D.
Endocrinology, Diabetes & Metabolism Physician in NOBLESVILLE, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: JOSE CARO, M.D. filed 63 Medicare Part D claims in 2023 across NOBLESVILLE, Indiana. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
JOSE CARO, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
JOSE CARO, M.D. at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Indiana
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Indiana providers
Endocrinology, Diabetes & Metabolism Physician share within Indiana
Endocrinology, Diabetes & Metabolism Physician is one of the more visible NUCC categories in Indiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Endocrinology, Diabetes & Metabolism Physician US NPIs
Specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JOSE CARO, M.D. is a Endocrinology, Diabetes & Metabolism Physician provider practicing in NOBLESVILLE, Indiana, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1356781983. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
JOSE CARO, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 1296 CONNER ST, NOBLESVILLE, IN, 46060, with a listed phone of (252) 414-1738. NPI 1356781983 was issued on 06/27/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CARO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 63 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $32K in drug spend, split 35% brand-name and 65% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1356781983 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/27/2013 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JOSE CARO, M.D.'s current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
Brand vs generic prescribing mix · Above average
35% brand-name claims vs 65% generic, on 63 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 130
- Total Day Supply
- 3,748
- Brand vs Generic
- 35% brand / 65% generic
- Brand Drug Cost
- $29K
- Generic Drug Cost
- $3K
Patient Demographics
- Average Patient Age
- 73.5 years
- Avg HCC Risk Score
- 0.69
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Mounjaro Tirzepatide | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How JOSE CARO, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
JOSE CARO, M.D.'s 63 claims are below the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as CARO.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Indiana
Frequently Asked Questions
What is JOSE CARO, M.D.'s specialty? ▼
How much does JOSE CARO, M.D. prescribe under Medicare Part D? ▼
Where is JOSE CARO, M.D. located? ▼
What is JOSE CARO, M.D.'s NPI number? ▼
Does JOSE CARO, M.D. prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does JOSE CARO, M.D. prescribe most often? ▼
Does JOSE CARO, M.D. accept Medicare? ▼
How can I verify JOSE CARO, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology